Cytokinetics Inc (CYTK)
Days of sales outstanding (DSO)
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Receivables turnover | — | — | — | — | — | |
DSO | days | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
Based on the provided data, it appears that the days of sales outstanding (DSO) for Cytokinetics Inc are not available or have been redacted for the years ending December 31, 2020 through December 31, 2024. Without specific DSO figures for these years, it is challenging to assess the efficiency of the company in collecting its accounts receivable and managing its credit sales in relation to its revenue generation and industry benchmarks. For a comprehensive analysis of Cytokinetics Inc's DSO and its implications, accurate figures or historical trends for the DSO ratio would be necessary.
Peer comparison
Dec 31, 2024
Company name
Symbol
DSO
Cytokinetics Inc
CYTK
—
Abbott Laboratories
ABT
—
AbbVie Inc
ABBV
—
ACADIA Pharmaceuticals Inc
ACAD
—
Alkermes Plc
ALKS
90.15
Amphastar P
AMPH
67.96
ANI Pharmaceuticals Inc
ANIP
—
Arcus Biosciences Inc
RCUS
7.07
Biomarin Pharmaceutical Inc
BMRN
84.73
Bristol-Myers Squibb Company
BMY
81.21
Catalyst Pharmaceuticals Inc
CPRX
—